Safety and Efficacy of Fingolimod in Schizophrenia Patients Who Have Suboptimal Responses to Antipsychotic Drug Treatment
Phase of Trial: Phase II
Latest Information Update: 17 Apr 2019
At a glance
- Drugs Fingolimod (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions; Proof of concept
- Acronyms STEP
- 25 Mar 2019 Status changed from active, no longer recruiting to completed.
- 09 Oct 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2017.
- 30 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.